import "dotenv/config";
import { Role, PostStatus } from "../lib/generated/prisma";
import { createPrismaClient } from "../lib/prisma-factory";
import { hash } from "bcryptjs";

const prisma = createPrismaClient();

async function main() {
  console.log("🌱 Starting database seed...");

  // =============================================================================
  // SEED CATEGORIES
  // =============================================================================
  console.log("📁 Creating blog categories...");

  const categories = [
    {
      name: "Manufacturing Engineering",
      slug: "manufacturing-engineering",
      description:
        "Insights on manufacturing processes, operations excellence, and production optimization for medical devices.",
      sortOrder: 1,
    },
    {
      name: "Quality Systems & Compliance",
      slug: "quality-systems-compliance",
      description:
        "Articles covering ISO 13485, FDA regulations, EU MDR, MDSAP, and quality management systems.",
      sortOrder: 2,
    },
    {
      name: "Process Development",
      slug: "process-development",
      description:
        "Technical content on process validation, scientific molding, and process optimization.",
      sortOrder: 3,
    },
    {
      name: "Facility Design",
      slug: "facility-design",
      description:
        "Best practices for cleanroom design, facility layout, and manufacturing infrastructure.",
      sortOrder: 4,
    },
    {
      name: "Equipment & Mold Maintenance",
      slug: "equipment-mold-maintenance",
      description:
        "Guides on preventive maintenance programs, equipment lifecycle management, and mold maintenance strategies.",
      sortOrder: 5,
    },
    {
      name: "Industry Trends",
      slug: "industry-trends",
      description:
        "Updates on medical device industry developments, emerging technologies, and market insights.",
      sortOrder: 6,
    },
    {
      name: "Case Studies",
      slug: "case-studies",
      description:
        "Real-world examples and success stories from medical device consulting projects.",
      sortOrder: 7,
    },
  ];

  const categoryMap: Record<string, string> = {};

  for (const category of categories) {
    const created = await prisma.category.upsert({
      where: { slug: category.slug },
      update: category,
      create: category,
    });
    categoryMap[category.slug] = created.id;
  }

  console.log(`✅ Created ${categories.length} categories`);

  // =============================================================================
  // SEED ADMIN USER
  // =============================================================================
  console.log("👤 Creating admin user...");

  const adminEmail = process.env.ADMIN_EMAIL || "admin@sidecconsult.com";
  const adminPassword = process.env.ADMIN_PASSWORD || "ChangeMe123!";

  // Hash password with 10 rounds (as specified in requirements)
  const passwordHash = await hash(adminPassword, 10);

  const adminUser = await prisma.user.upsert({
    where: { email: adminEmail },
    update: {
      name: "Admin User",
      role: Role.ADMIN,
      passwordHash,
    },
    create: {
      email: adminEmail,
      name: "Admin User",
      role: Role.ADMIN,
      passwordHash,
    },
  });

  console.log(`✅ Admin user created: ${adminUser.email}`);

  // =============================================================================
  // SEED BLOG POSTS
  // =============================================================================
  console.log("📝 Creating blog posts...");

  const blogPosts = [
    // =========================================================================
    // MANUFACTURING ENGINEERING (4 posts)
    // =========================================================================
    {
      title: "Optimizing Injection Molding Cycle Times for Medical Device Components",
      slug: "optimizing-injection-molding-cycle-times-medical-devices",
      excerpt: "Learn proven strategies to reduce injection molding cycle times while maintaining the stringent quality standards required for medical device manufacturing.",
      content: `## Introduction

Injection molding cycle time optimization is one of the most impactful improvements a medical device manufacturer can make. Even small reductions in cycle time can translate to significant cost savings and increased production capacity. However, in the medical device industry, any optimization must be balanced against the critical need to maintain product quality and regulatory compliance.

## Understanding Cycle Time Components

A typical injection molding cycle consists of several phases:

### 1. Injection Phase
The injection phase involves filling the mold cavity with molten plastic. Key factors affecting this phase include:
- Injection speed and pressure profiles
- Melt temperature
- Gate design and location
- Part geometry and wall thickness

### 2. Packing and Holding Phase
During packing, additional material is forced into the cavity to compensate for shrinkage. Optimization opportunities include:
- Pressure profiling to minimize cycle time while ensuring complete packing
- Switchover point optimization
- Hold time studies to determine minimum effective duration

### 3. Cooling Phase
Cooling typically represents 50-70% of total cycle time, making it the primary target for optimization:
- Conformal cooling channel design
- Coolant temperature and flow rate optimization
- Mold material selection for improved thermal conductivity
- Thermal analysis and simulation

### 4. Mold Open and Ejection
This phase includes mold opening, part ejection, and mold closing:
- Optimized clamp movements
- Efficient ejection systems
- Robot extraction timing

## Scientific Molding Approach

The foundation of cycle time optimization in medical device manufacturing is scientific molding. This methodology uses data-driven decisions rather than trial-and-error approaches.

### Process Development Steps:
1. **Rheology Study**: Determine optimal injection velocity through viscosity curve analysis
2. **Pressure Drop Study**: Identify pressure requirements for each phase
3. **Gate Seal Study**: Establish minimum pack/hold time
4. **Cooling Study**: Determine optimal cooling time based on part temperature

### Documentation Requirements
For medical devices, all optimization activities must be documented within your quality management system:
- Design of Experiments (DOE) protocols
- Process validation protocols (IQ/OQ/PQ)
- Change control documentation
- Risk assessment updates

## Case Example: 35% Cycle Time Reduction

A recent project involved optimizing the production of a Class II medical device housing. The initial cycle time was 45 seconds. Through systematic analysis:

- Conformal cooling reduced cooling time by 12 seconds
- Injection profile optimization saved 3 seconds
- Gate seal study identified 2 seconds of unnecessary hold time
- Mold movement optimization saved 1.5 seconds

**Result**: 29 seconds cycle time (35% reduction) with improved part quality and reduced warpage.

## Quality Considerations

Any cycle time optimization must include:
- Dimensional verification across the operating window
- Functional testing validation
- Visual quality assessment
- Documentation for regulatory submissions

## Conclusion

Cycle time optimization in medical device injection molding requires a systematic, scientific approach. By understanding each phase of the cycle and applying data-driven optimization techniques, manufacturers can achieve significant improvements while maintaining the quality standards essential for medical devices.`,
      featuredImage: "https://images.unsplash.com/photo-1581091226825-a6a2a5aee158?w=1200",
      status: PostStatus.PUBLISHED,
      publishedAt: new Date("2025-12-15"),
      metaTitle: "Optimizing Injection Molding Cycle Times for Medical Devices | SIDEC Consult",
      metaDescription: "Expert guide on reducing injection molding cycle times in medical device manufacturing while maintaining quality and regulatory compliance.",
      readingTime: 8,
      categorySlug: "manufacturing-engineering",
    },
    {
      title: "Implementing Lean Manufacturing in Medical Device Production",
      slug: "implementing-lean-manufacturing-medical-device-production",
      excerpt: "A comprehensive guide to applying lean manufacturing principles in regulated medical device environments while maintaining compliance.",
      content: `## Introduction

Lean manufacturing has transformed industries worldwide, and the medical device sector is no exception. However, implementing lean principles in a heavily regulated environment requires careful consideration of compliance requirements alongside efficiency gains.

## The Seven Wastes in Medical Device Manufacturing

### 1. Overproduction
Producing more than customer demand requires is particularly problematic in medical devices due to:
- Shelf life considerations for sterile products
- Storage costs for controlled environments
- Risk of obsolescence from design changes

**Solution**: Implement pull-based production systems with kanban controls.

### 2. Waiting
Common waiting wastes in medical device manufacturing:
- Waiting for quality approvals
- Waiting for documentation review
- Equipment setup and changeover time

**Solution**: Streamline approval workflows, implement electronic quality systems, and optimize changeover procedures.

### 3. Transportation
Unnecessary movement of materials creates risk and inefficiency:
- Contamination risk during transfers
- Documentation burden for material tracking
- Time delays in production flow

**Solution**: Optimize facility layout to minimize material travel distances while maintaining required segregation.

### 4. Over-Processing
Performing more work than necessary:
- Excessive inspection points
- Redundant documentation
- Over-specification of requirements

**Solution**: Risk-based approach to quality controls, process capability studies to justify reduced inspection.

### 5. Inventory
Excess inventory ties up capital and creates quality risks:
- Material expiration concerns
- Storage space requirements
- Traceability complexity

**Solution**: Just-in-time delivery agreements with qualified suppliers, optimized safety stock calculations.

### 6. Motion
Unnecessary movement of people:
- Searching for tools or documentation
- Walking between workstations
- Reaching for materials

**Solution**: 5S workplace organization, ergonomic workstation design, visual management systems.

### 7. Defects
Quality issues waste resources and risk patient safety:
- Scrap and rework costs
- Investigation and CAPA burden
- Potential regulatory impact

**Solution**: Error-proofing (poka-yoke), statistical process control, root cause analysis culture.

## Lean Tools for Medical Device Manufacturing

### Value Stream Mapping
Map the entire production process from raw materials to finished goods:
1. Document current state including all quality hold points
2. Identify non-value-added activities
3. Design future state with regulatory requirements considered
4. Create implementation roadmap

### 5S Implementation
The foundation of lean workplace organization:
- **Sort**: Remove unnecessary items from the work area
- **Set in Order**: Organize remaining items for efficiency
- **Shine**: Clean and maintain the workspace
- **Standardize**: Create standard procedures for maintaining organization
- **Sustain**: Regular audits and continuous improvement

### Standard Work
Develop detailed work instructions that:
- Ensure consistent quality output
- Support training and qualification
- Meet regulatory documentation requirements
- Enable continuous improvement

## Balancing Lean with Compliance

### Documentation Requirements
Lean principles sometimes conflict with regulatory documentation needs. Strategies include:
- Electronic batch records to reduce paperwork while maintaining compliance
- Risk-based documentation approaches
- Integrated quality management systems

### Change Control Considerations
Lean improvements often require formal change control:
- Assess regulatory impact of each change
- Determine validation requirements
- Update affected procedures and training

### Supplier Management
Lean supplier relationships must consider:
- Supplier qualification requirements
- Incoming inspection protocols
- Traceability requirements

## Measuring Success

Key performance indicators for lean medical device manufacturing:
- Overall Equipment Effectiveness (OEE)
- First Pass Yield (FPY)
- On-time delivery
- Inventory turns
- Customer complaints
- Audit findings

## Conclusion

Lean manufacturing principles can significantly improve medical device operations when implemented thoughtfully. Success requires understanding both lean methodologies and regulatory requirements, then finding the optimal balance for your specific products and processes.`,
      featuredImage: "https://images.unsplash.com/photo-1565043589221-1a6fd9ae45c7?w=1200",
      status: PostStatus.PUBLISHED,
      publishedAt: new Date("2025-12-10"),
      metaTitle: "Lean Manufacturing in Medical Device Production | SIDEC Consult",
      metaDescription: "Learn how to implement lean manufacturing principles in medical device production while maintaining regulatory compliance and quality standards.",
      readingTime: 10,
      categorySlug: "manufacturing-engineering",
    },
    {
      title: "Production Line Balancing Strategies for Medical Device Assembly",
      slug: "production-line-balancing-medical-device-assembly",
      excerpt: "Master the art of balancing medical device assembly lines to maximize throughput while ensuring quality and compliance at every station.",
      content: `## Introduction

Production line balancing is critical for efficient medical device assembly operations. A well-balanced line maximizes throughput, minimizes work-in-process inventory, and ensures consistent quality. This article explores strategies specifically tailored for medical device manufacturing environments.

## Understanding Line Balancing Fundamentals

### Takt Time Calculation
Takt time is the rate at which products must be completed to meet customer demand:

**Takt Time = Available Production Time / Customer Demand**

For example:
- Available time: 450 minutes per shift
- Customer demand: 150 units per shift
- Takt time: 3 minutes per unit

### Cycle Time vs. Takt Time
- **Cycle time**: Actual time to complete a task
- **Takt time**: Required pace to meet demand
- Goal: Cycle time ≤ Takt time at all stations

## Challenges Unique to Medical Device Assembly

### 1. Quality Inspection Integration
Medical devices often require:
- In-process inspections at critical points
- Documentation and verification steps
- Test procedures that cannot be compressed

**Strategy**: Include inspection time in station cycle time calculations; consider automated inspection where possible.

### 2. Operator Qualification Requirements
Different stations may require:
- Specific training certifications
- Competency validations
- Process-specific qualifications

**Strategy**: Cross-train operators to increase flexibility; maintain qualification matrices.

### 3. Cleanroom Constraints
Assembly in controlled environments limits:
- Number of operators per area
- Types of equipment allowed
- Material handling methods

**Strategy**: Design for cleanroom efficiency; optimize gowning and material transfer procedures.

## Line Balancing Methodologies

### Method 1: Largest Candidate Rule
1. List all tasks in descending order of time
2. Assign tasks to stations without exceeding takt time
3. Start new station when current cannot accommodate more tasks

### Method 2: Ranked Positional Weight
1. Calculate positional weight for each task (task time + all following task times)
2. Assign tasks by highest positional weight
3. Respect precedence constraints

### Method 3: Simulation-Based Balancing
Use discrete event simulation to:
- Model variability in task times
- Evaluate different configurations
- Identify bottlenecks and buffer requirements

## Practical Implementation Steps

### Step 1: Document Current State
- Time studies for all assembly tasks
- Identify precedence relationships
- Map current line configuration
- Measure actual cycle times and variability

### Step 2: Analyze Constraints
- Regulatory inspection requirements
- Equipment placement limitations
- Operator qualification constraints
- Cleanroom or environmental controls

### Step 3: Develop Options
Create multiple line configurations considering:
- Different numbers of stations
- Alternative task assignments
- Inspection point locations
- Buffer placement

### Step 4: Evaluate and Select
Compare options using:
- Line efficiency: (Sum of task times) / (Number of stations × Takt time)
- Balance delay: Idle time across all stations
- Flexibility for demand changes
- Quality risk assessment

### Step 5: Implement with Change Control
- Document changes per quality system requirements
- Update work instructions and training
- Validate new configuration
- Monitor performance post-implementation

## Visual Management for Balanced Lines

### Production Boards
Display real-time information:
- Hourly production targets vs. actual
- Quality metrics
- Station status indicators

### Andon Systems
Enable quick response to issues:
- Station call lights
- Escalation protocols
- Response time tracking

### Work-in-Process Limits
Visual indicators for WIP control:
- Kanban squares between stations
- Maximum quantity indicators
- FIFO lane markings

## Handling Variability

### Common Sources of Variability
- Operator skill differences
- Component quality variation
- Equipment reliability
- Documentation requirements

### Mitigation Strategies
1. **Buffer inventory**: Strategic WIP between stations
2. **Floating operators**: Cross-trained personnel for support
3. **Parallel operations**: Multiple stations for bottleneck tasks
4. **Standard work**: Detailed procedures to reduce variation

## Continuous Improvement

### Regular Review Cadence
- Daily: Production vs. target review
- Weekly: Line efficiency metrics
- Monthly: Comprehensive balance analysis
- Quarterly: Demand forecast alignment

### Improvement Opportunities
- Task time reduction through kaizen
- Automation of repetitive tasks
- Error-proofing to reduce rework
- Layout optimization

## Conclusion

Effective line balancing in medical device assembly requires understanding both industrial engineering principles and the unique requirements of regulated manufacturing. By systematically analyzing constraints, developing balanced configurations, and implementing with appropriate change control, manufacturers can achieve significant improvements in efficiency while maintaining quality and compliance.`,
      featuredImage: "https://images.unsplash.com/photo-1581092160562-40aa08e78837?w=1200",
      status: PostStatus.PUBLISHED,
      publishedAt: new Date("2025-12-05"),
      metaTitle: "Production Line Balancing for Medical Device Assembly | SIDEC Consult",
      metaDescription: "Expert strategies for balancing medical device assembly lines to maximize throughput while maintaining quality compliance.",
      readingTime: 9,
      categorySlug: "manufacturing-engineering",
    },
    {
      title: "Material Flow Optimization in Medical Device Manufacturing Facilities",
      slug: "material-flow-optimization-medical-device-manufacturing",
      excerpt: "Discover how to design efficient material flow systems that maintain traceability and quality while reducing waste in medical device facilities.",
      content: `## Introduction

Efficient material flow is the backbone of successful medical device manufacturing. Unlike general manufacturing, medical device facilities must balance operational efficiency with stringent traceability requirements, contamination control, and regulatory compliance. This guide explores strategies for optimizing material flow while meeting these critical requirements.

## Principles of Medical Device Material Flow

### 1. Unidirectional Flow
Design material flow to move in one direction from raw materials to finished goods:
- Prevents cross-contamination
- Simplifies traceability
- Reduces confusion and errors

### 2. Segregation Requirements
Maintain appropriate separation between:
- Raw materials and finished goods
- Conforming and non-conforming materials
- Different product families (when required)
- Clean and non-clean areas

### 3. Traceability at Every Step
Material flow systems must support:
- Lot/batch tracking
- First-In-First-Out (FIFO) management
- Electronic or physical documentation
- Recall capability

## Material Flow Analysis

### Current State Mapping
Document existing material flow:
1. Create spaghetti diagrams showing actual movement paths
2. Calculate total travel distances
3. Identify crossing flows and congestion points
4. Map handling touchpoints

### Data Collection
Gather metrics on:
- Material handling time per unit
- Wait times at each stage
- Inventory levels at each location
- Non-conformance rates by location

### Waste Identification
Common material flow wastes:
- **Transportation**: Excessive movement between areas
- **Inventory**: Materials waiting in queues
- **Motion**: Operators searching for materials
- **Waiting**: Production delays for material availability

## Facility Layout Strategies

### Cellular Manufacturing
Group operations for product families:
- Reduced material travel
- Improved communication
- Faster feedback on quality issues

### Point-of-Use Storage
Position materials near consumption:
- Minimize operator travel
- Reduce handling damage risk
- Improve inventory visibility

### Supermarket Systems
Create controlled inventory locations:
- Fixed locations for each material
- Visual management of quantities
- Kanban replenishment signals

## Material Handling Systems

### Manual vs. Automated Handling
Consider factors:
- Volume and frequency of movements
- Contamination control requirements
- Traceability needs
- Investment justification

### Cleanroom Material Transfer
Special considerations for controlled environments:
- Pass-through chambers and airlocks
- Decontamination procedures
- Gowning and de-gowning flows
- Container and packaging requirements

### Automated Guided Vehicles (AGVs)
Benefits for medical device facilities:
- Consistent handling reduces damage
- Automatic documentation of movements
- Reduced contamination from human handling
- 24/7 operation capability

## Warehouse and Storage Optimization

### Inventory Classification
ABC analysis for storage decisions:
- **A items**: High-value, high-usage (prime locations)
- **B items**: Medium value/usage (secondary locations)
- **C items**: Low-value, low-usage (remote storage acceptable)

### Environmental Requirements
Storage conditions must meet specifications:
- Temperature and humidity control
- Light protection (for sensitive materials)
- ESD protection (for electronic components)
- Shelf-life management

### Location Management
Implement systematic location systems:
- Logical numbering conventions
- Barcode or RFID identification
- Integration with inventory management system
- Regular location audits

## Information Flow Integration

### Material Requirements Planning
Ensure material flow aligns with:
- Production schedules
- Customer demand
- Supplier lead times
- Safety stock requirements

### Electronic Batch Records
Integrate material tracking with:
- Component scanning at each operation
- Automatic lot assignment
- Real-time inventory updates
- Exception alerts

### Supplier Integration
Collaborate with suppliers on:
- Delivery scheduling
- Packaging and labeling standards
- Quality documentation
- Emergency response procedures

## Implementation Approach

### Phase 1: Quick Wins
Implement immediately actionable improvements:
- 5S organization of storage areas
- Visual management systems
- Clear labeling and signage

### Phase 2: System Changes
Medium-term improvements:
- Layout modifications
- New material handling equipment
- Software system upgrades

### Phase 3: Strategic Investments
Long-term transformations:
- Facility expansion or reconfiguration
- Automation systems
- Supply chain restructuring

## Measuring Success

### Key Performance Indicators
- Material travel distance per unit
- Inventory accuracy
- FIFO compliance rate
- Material-related production delays
- Handling damage rate
- Traceability retrieval time

### Audit Program
Regular verification of:
- Storage condition compliance
- Location accuracy
- FIFO adherence
- Documentation completeness

## Conclusion

Optimizing material flow in medical device manufacturing requires balancing efficiency with regulatory requirements. Success comes from systematic analysis of current state, thoughtful design of improvements, and disciplined implementation with appropriate change controls. The investment in material flow optimization pays dividends in reduced costs, improved quality, and enhanced compliance.`,
      featuredImage: "https://images.unsplash.com/photo-1586528116311-ad8dd3c8310d?w=1200",
      status: PostStatus.PUBLISHED,
      publishedAt: new Date("2025-11-28"),
      metaTitle: "Material Flow Optimization in Medical Device Manufacturing | SIDEC Consult",
      metaDescription: "Learn strategies for optimizing material flow in medical device facilities while maintaining traceability and regulatory compliance.",
      readingTime: 10,
      categorySlug: "manufacturing-engineering",
    },

    // =========================================================================
    // QUALITY SYSTEMS & COMPLIANCE (4 posts)
    // =========================================================================
    {
      title: "Navigating EU MDR: A Practical Implementation Guide",
      slug: "navigating-eu-mdr-practical-implementation-guide",
      excerpt: "A step-by-step guide to implementing European Medical Device Regulation (EU MDR) requirements in your quality management system.",
      content: `## Introduction

The European Medical Device Regulation (EU MDR 2017/745) represents a significant evolution from the previous Medical Device Directive (MDD). With stricter requirements for clinical evidence, post-market surveillance, and quality management, manufacturers must adapt their systems to achieve and maintain compliance. This guide provides practical steps for implementation.

## Key Changes from MDD to MDR

### Enhanced Clinical Evidence Requirements
- Clinical evaluation must be ongoing throughout device lifecycle
- Greater emphasis on clinical investigation data
- Equivalence claims face stricter scrutiny
- Post-market clinical follow-up (PMCF) is mandatory for most devices

### Strengthened Post-Market Surveillance
- Systematic PMS planning and execution
- Periodic Safety Update Reports (PSUR) for higher-risk devices
- Trend reporting and vigilance improvements
- Active feedback collection requirements

### Quality Management System Updates
- Persons responsible for regulatory compliance
- UDI implementation
- Enhanced traceability requirements
- Economic operator obligations

### Documentation Requirements
- Technical documentation structure updates
- Summary of Safety and Clinical Performance (SSCP)
- EUDAMED registration requirements

## Implementation Roadmap

### Phase 1: Gap Assessment (Months 1-3)

#### Step 1: Regulatory Classification Review
- Reclassify all devices under MDR rules
- Identify devices with classification changes
- Assess impact on conformity assessment routes

#### Step 2: Technical Documentation Gap Analysis
Compare current technical files against MDR requirements:
- General Safety and Performance Requirements (GSPR) checklist
- Clinical evaluation report adequacy
- Risk management file completeness
- Labeling and IFU compliance

#### Step 3: QMS Gap Analysis
Evaluate quality system against MDR requirements:
- Process for responsible persons
- Post-market surveillance procedures
- Supplier and subcontractor controls
- Complaint handling and vigilance

### Phase 2: Planning and Resource Allocation (Months 4-6)

#### Prioritization Matrix
Categorize required changes:
- **Critical**: Changes required for CE marking
- **Major**: Significant process updates needed
- **Minor**: Documentation or procedural updates

#### Resource Planning
Identify requirements for:
- Internal personnel training
- External consulting support
- Clinical studies or data collection
- System upgrades (UDI, EUDAMED)

#### Project Timeline
Develop detailed project plan:
- Milestone definitions
- Resource assignments
- Dependency mapping
- Risk mitigation strategies

### Phase 3: Implementation (Months 7-18)

#### Clinical Evaluation Updates
1. Establish literature search protocols meeting MDR requirements
2. Define equivalence assessment procedures
3. Develop PMCF plans and procedures
4. Create clinical evaluation report templates

#### Post-Market Surveillance Enhancement
1. Implement proactive data collection systems
2. Establish trend analysis procedures
3. Create PSUR templates and schedules
4. Update complaint handling processes

#### QMS Procedure Updates
1. Revise design and development procedures
2. Update supplier management processes
3. Enhance production and process controls
4. Implement UDI procedures

#### Technical Documentation Updates
1. Restructure technical files to MDR format
2. Update GSPR checklists
3. Revise labeling and IFU
4. Prepare Summary of Safety and Clinical Performance

### Phase 4: Verification and Notified Body Engagement (Months 19-24)

#### Internal Audit Program
- Conduct comprehensive audits against MDR requirements
- Verify implementation effectiveness
- Address findings before Notified Body review

#### Notified Body Preparation
- Submit application to MDR-designated Notified Body
- Prepare for document review
- Plan for on-site assessment
- Address queries and findings

## Common Implementation Challenges

### Challenge 1: Clinical Evidence Gaps
**Issue**: Insufficient clinical data for MDR requirements
**Solutions**:
- Initiate PMCF studies early
- Leverage real-world evidence
- Consider clinical investigation for high-risk devices
- Reassess equivalence claims critically

### Challenge 2: Resource Constraints
**Issue**: Limited internal expertise or capacity
**Solutions**:
- Prioritize portfolio (consider discontinuing some devices)
- Engage specialized consultants
- Collaborate with industry groups
- Leverage regulatory agency guidance

### Challenge 3: Notified Body Availability
**Issue**: Limited MDR-designated Notified Body capacity
**Solutions**:
- Engage early with Notified Body
- Maintain clear communication
- Prepare thorough documentation
- Address feedback promptly

### Challenge 4: Legacy Device Challenges
**Issue**: Older devices lacking documentation
**Solutions**:
- Reconstruct technical documentation
- Generate supporting clinical data
- Consider device redesign if necessary
- Evaluate market withdrawal for marginal products

## EUDAMED and UDI Implementation

### Unique Device Identification (UDI)
- Register with accredited issuing agency
- Implement UDI carriers on labels and packaging
- Establish processes for UDI maintenance
- Integrate with quality management system

### EUDAMED Registration
Prepare for database registration:
- Actor registration
- UDI/Device registration
- Certificate and Notified Body information
- Vigilance and post-market surveillance data

## Maintaining Compliance

### Ongoing Requirements
- Annual surveillance audits
- PSUR submissions (as applicable)
- PMCF implementation
- Vigilance reporting
- Technical documentation updates

### Change Management
- Assess MDR impact for all changes
- Determine if Notified Body notification required
- Maintain documentation currency
- Update clinical evaluation as needed

## Conclusion

EU MDR implementation is a substantial undertaking requiring careful planning, adequate resources, and sustained commitment. By following a structured approach and addressing challenges proactively, manufacturers can achieve compliance while maintaining market access for their medical devices in the European Union.`,
      featuredImage: "https://images.unsplash.com/photo-1589829545856-d10d557cf95f?w=1200",
      status: PostStatus.PUBLISHED,
      publishedAt: new Date("2025-11-22"),
      metaTitle: "EU MDR Implementation Guide for Medical Device Manufacturers | SIDEC Consult",
      metaDescription: "Practical step-by-step guide for implementing European Medical Device Regulation (EU MDR) requirements in your quality management system.",
      readingTime: 12,
      categorySlug: "quality-systems-compliance",
    },
    {
      title: "Building a Robust CAPA System for Medical Device Companies",
      slug: "building-robust-capa-system-medical-device-companies",
      excerpt: "Learn how to design and implement an effective Corrective and Preventive Action (CAPA) system that drives continuous improvement while satisfying regulatory requirements.",
      content: `## Introduction

Corrective and Preventive Action (CAPA) is the cornerstone of any medical device quality management system. A well-designed CAPA system not only satisfies regulatory requirements but drives genuine continuous improvement. This article provides practical guidance for building a CAPA system that works.

## Understanding CAPA Requirements

### Regulatory Framework
CAPA requirements are defined in multiple regulations:
- **FDA 21 CFR 820.100**: Quality System Regulation
- **ISO 13485:2016 Section 8.5**: Improvement
- **EU MDR Annex IX**: Quality management system requirements

### The Difference Between Corrective and Preventive Action

**Corrective Action**: Addresses existing nonconformities
- Eliminates the root cause of detected problems
- Prevents recurrence of issues that have already occurred
- Reactive in nature but systematic in approach

**Preventive Action**: Addresses potential nonconformities
- Eliminates the root cause of potential problems
- Prevents occurrence of issues that haven't happened yet
- Proactive and forward-looking

## CAPA Process Design

### Step 1: Identification and Input Sources
Effective CAPA systems capture inputs from multiple sources:

**Internal Sources:**
- Nonconforming material reports
- Internal audit findings
- Process monitoring data
- Employee observations
- Management review outputs

**External Sources:**
- Customer complaints
- Field service reports
- Supplier quality issues
- Regulatory feedback
- Industry recalls and advisories

### Step 2: Evaluation and Prioritization
Not every issue requires a CAPA. Establish criteria for:

**CAPA Triggers:**
- Recurring nonconformances
- Safety-related issues
- Regulatory findings
- Significant customer impact
- Systemic process failures

**Risk-Based Prioritization:**
- Severity of potential patient impact
- Probability of recurrence
- Detectability of the issue
- Regulatory implications

### Step 3: Investigation and Root Cause Analysis
The heart of effective CAPA is thorough investigation:

**Investigation Planning:**
- Define scope and objectives
- Identify team members and responsibilities
- Establish timeline
- Gather relevant data and documentation

**Root Cause Analysis Tools:**
- 5 Whys analysis for simple problems
- Fishbone (Ishikawa) diagrams for categorizing causes
- Fault Tree Analysis for complex issues
- Is/Is Not analysis for problem definition

**Common Pitfalls:**
- Stopping at symptoms rather than root causes
- Blaming individuals rather than systems
- Insufficient data collection
- Time pressure leading to superficial analysis

### Step 4: Action Planning
Develop comprehensive action plans:

**Immediate Actions (Containment):**
- Address immediate risk or nonconformity
- Implement temporary controls
- Communicate to affected parties

**Corrective/Preventive Actions:**
- Target root cause elimination
- Define specific, measurable actions
- Assign clear ownership
- Establish realistic timelines
- Consider validation requirements

### Step 5: Implementation
Execute planned actions effectively:

**Change Control Integration:**
- Process changes through formal change control
- Document procedure revisions
- Update training requirements

**Communication:**
- Notify affected departments
- Update relevant stakeholders
- Document implementation evidence

### Step 6: Verification of Effectiveness
Confirm that actions achieved intended results:

**Verification Methods:**
- Data trend analysis
- Process capability studies
- Audit of implemented changes
- Review of similar issues

**Timing Considerations:**
- Allow sufficient time for effectiveness demonstration
- Consider multiple verification points
- Avoid premature closure

### Step 7: Closure and Documentation
Complete the CAPA with thorough documentation:

**Closure Criteria:**
- Root cause identified and documented
- Actions implemented and verified effective
- Appropriate approvals obtained
- Lessons learned captured

## CAPA Metrics and Monitoring

### Key Performance Indicators
Track CAPA system health:
- Number of open CAPAs by age
- On-time completion rate
- Effectiveness verification pass rate
- Time from identification to closure
- CAPAs by source category
- Recurrence rate

### Management Review
Regular review of CAPA trends:
- Identify systemic issues
- Allocate resources appropriately
- Drive strategic improvements
- Demonstrate management commitment

## Common CAPA System Problems

### Problem 1: CAPA Overload
**Symptoms**: Too many open CAPAs, inability to complete on time
**Solutions**:
- Raise threshold for CAPA initiation
- Improve initial evaluation process
- Batch similar issues
- Allocate dedicated resources

### Problem 2: Ineffective Root Cause Analysis
**Symptoms**: Recurring issues, actions that don't prevent recurrence
**Solutions**:
- Training on RCA techniques
- Require evidence-based analysis
- Peer review of investigations
- Extended verification periods

### Problem 3: Documentation Burden
**Symptoms**: Extensive time on paperwork, delayed closures
**Solutions**:
- Electronic CAPA management systems
- Streamlined forms and templates
- Risk-based documentation requirements
- Clear procedural guidance

## Integration with Other Quality Processes

### Complaint Handling
- Direct input to CAPA system
- Trending analysis for preventive action
- Closed-loop feedback

### Nonconforming Material
- Recurring NCRs trigger CAPA
- CAPA addresses systemic issues
- NCR for individual events

### Internal Audits
- Findings may require CAPA
- CAPA effectiveness verified during audits
- System-level improvements identified

### Risk Management
- CAPA informs risk analysis updates
- Risk assessments guide CAPA prioritization
- Continuous risk-benefit evaluation

## Conclusion

A robust CAPA system is essential for medical device quality and regulatory compliance. Success requires clear procedures, adequate resources, trained personnel, and management commitment. When designed and implemented effectively, CAPA becomes a powerful tool for continuous improvement rather than just a regulatory checkbox.`,
      featuredImage: "https://images.unsplash.com/photo-1454165804606-c3d57bc86b40?w=1200",
      status: PostStatus.PUBLISHED,
      publishedAt: new Date("2025-11-18"),
      metaTitle: "Building a Robust CAPA System for Medical Devices | SIDEC Consult",
      metaDescription: "Practical guide to designing and implementing an effective CAPA system that drives continuous improvement in medical device manufacturing.",
      readingTime: 11,
      categorySlug: "quality-systems-compliance",
    },
    {
      title: "FDA 483 Observations: Prevention, Response, and Resolution",
      slug: "fda-483-observations-prevention-response-resolution",
      excerpt: "Understanding FDA Form 483 observations and developing effective strategies for prevention, timely response, and sustainable resolution.",
      content: `## Introduction

Receiving FDA Form 483 observations during an inspection can be stressful, but it's a normal part of regulatory oversight. How you prevent, respond to, and resolve these observations reflects your company's commitment to quality and can significantly impact your regulatory standing. This guide provides practical strategies for each phase.

## Understanding FDA Form 483

### What is Form 483?
FDA Form 483 is issued at the conclusion of an inspection when investigators observe conditions that may constitute violations of the Food Drug and Cosmetic Act and related regulations. Key points:

- Observations are the investigator's opinion, not final FDA conclusions
- A 483 is not a formal finding of violation
- Observations require evaluation and response
- Failure to respond appropriately can lead to warning letters

### Common 483 Categories for Medical Devices

**Design Controls (21 CFR 820.30)**
- Incomplete design history files
- Inadequate design verification/validation
- Missing design reviews
- Poor requirements traceability

**CAPA (21 CFR 820.100)**
- Inadequate root cause analysis
- Failure to verify effectiveness
- Untimely completion of actions
- Not addressing all aspects of problems

**Complaint Handling (21 CFR 820.198)**
- Failure to investigate complaints
- Incomplete investigation documentation
- Not evaluating need for MDR
- Untimely processing

**Production and Process Controls (21 CFR 820.70)**
- Lack of process validation
- Inadequate process monitoring
- Environmental control deficiencies
- Equipment not properly maintained

**Supplier Controls (21 CFR 820.50)**
- Inadequate supplier evaluation
- Missing supplier agreements
- Insufficient incoming inspection
- Lack of ongoing monitoring

## Prevention Strategies

### Build a Culture of Compliance
- Leadership commitment to quality
- Adequate resources for quality functions
- Employee training and awareness
- Open communication about quality issues

### Implement Robust Systems
- Comprehensive procedures following regulations
- Adequate documentation practices
- Effective training programs
- Regular internal audits

### Mock FDA Inspections
Conduct periodic mock inspections:
- Use experienced auditors (internal or external)
- Follow FDA inspection approach
- Document and address findings
- Track trends over time

### Self-Assessment Programs
Regular evaluation of compliance status:
- Checklist-based assessments
- Gap analyses against regulations
- Benchmarking against industry practices
- Third-party audits

## During the Inspection

### Inspection Management
- Designate a trained escort team
- Control document access appropriately
- Take detailed notes of investigator requests
- Provide timely, accurate responses

### Real-Time Issue Management
- Address correctable issues immediately when possible
- Document actions taken during inspection
- Communicate openly with investigators
- Avoid defensive or confrontational responses

### End of Inspection
- Request detailed discussion of observations
- Clarify any unclear observations
- Begin response planning immediately
- Preserve all relevant documentation

## Response Strategy

### Timing
- Acknowledge receipt promptly
- Commit to response timeline (typically 15 business days)
- Request extension if needed for complex issues
- Submit response to correct district office

### Response Structure

**For Each Observation:**

1. **Acknowledgment**
   - Restate the observation
   - Acknowledge the concern
   - Avoid minimizing or dismissing

2. **Root Cause Analysis**
   - Describe investigation methodology
   - Present findings objectively
   - Identify systemic versus isolated issues

3. **Immediate Corrections**
   - Actions already taken
   - Evidence of completion
   - Scope of remediation

4. **Long-Term Corrective Actions**
   - Systemic improvements planned
   - Responsible parties and timelines
   - Validation or verification plans

5. **Preventive Measures**
   - Actions to prevent recurrence
   - Extension to similar processes
   - Monitoring plans

### Response Quality Tips
- Be thorough but concise
- Provide specific evidence
- Include realistic timelines
- Demonstrate understanding of the concern
- Show commitment to sustainable correction

## Resolution and Follow-Through

### Implementation Tracking
- Project management of all commitments
- Regular status reviews
- Executive visibility
- Documentation of completion

### Verification
- Confirm effectiveness of actions
- Gather objective evidence
- Allow adequate time for evaluation
- Document verification activities

### Communication with FDA
- Provide updates on major milestones
- Report completion of committed actions
- Be proactive about any delays
- Maintain professional relationship

### Preparing for Follow-Up
- Organize evidence of corrections
- Update relevant procedures
- Train affected personnel
- Be ready for re-inspection

## Escalation Scenarios

### Warning Letters
If 483 response is inadequate, FDA may issue a Warning Letter:
- More serious than 483
- Requires comprehensive response
- May affect regulatory submissions
- Often includes specific timeline demands

### Consent Decrees
For severe or repeated violations:
- Court-ordered agreement with FDA
- Significant operational restrictions
- Independent oversight requirements
- Substantial financial impact

### Prevention Focus
Best approach is preventing escalation:
- Take all 483s seriously
- Implement sustainable corrections
- Demonstrate commitment to compliance
- Maintain ongoing communication

## Building Inspection Readiness

### Documentation Practices
- Complete, contemporaneous records
- Organized and accessible files
- Regular documentation audits
- Clear retention policies

### Personnel Preparation
- Role-specific inspection training
- Understanding of regulations
- Practice sessions and mock inspections
- Confidence in system knowledge

### Continuous Improvement
- Use each inspection as learning opportunity
- Share lessons across organization
- Update systems based on industry trends
- Stay current with FDA guidance

## Conclusion

FDA 483 observations are opportunities to improve your quality systems. With effective prevention strategies, professional inspection conduct, thorough responses, and sustainable corrections, you can maintain positive regulatory relationships while continuously strengthening your compliance posture.`,
      featuredImage: "https://images.unsplash.com/photo-1450101499163-c8848c66ca85?w=1200",
      status: PostStatus.PUBLISHED,
      publishedAt: new Date("2025-11-12"),
      metaTitle: "FDA 483 Observations: Prevention, Response & Resolution | SIDEC Consult",
      metaDescription: "Comprehensive guide to preventing FDA 483 observations, responding effectively, and achieving sustainable resolution for medical device companies.",
      readingTime: 12,
      categorySlug: "quality-systems-compliance",
    },
    {
      title: "Risk Management Throughout the Medical Device Lifecycle",
      slug: "risk-management-throughout-medical-device-lifecycle",
      excerpt: "A comprehensive approach to implementing ISO 14971 risk management principles throughout design, manufacturing, and post-market phases.",
      content: `## Introduction

Risk management is not a one-time activity but a continuous process throughout the medical device lifecycle. ISO 14971 provides the framework for this process, but implementing it effectively requires understanding how risk management integrates with every phase of device development and commercialization.

## ISO 14971 Fundamentals

### Key Principles
- Risk management is an iterative process
- Residual risks must be acceptable
- Benefits must outweigh risks
- Information from production and post-production feeds back

### Risk Management Process Steps
1. Risk analysis
2. Risk evaluation
3. Risk control
4. Evaluation of overall residual risk
5. Risk management review
6. Production and post-production activities

## Risk Management in Design

### Early Design Phase

**Intended Use Definition**
- Clearly define intended use and user population
- Identify foreseeable misuse scenarios
- Establish operating environment conditions
- Define user skill requirements

**Hazard Identification**
Systematic identification of potential hazards:
- Energy hazards (electrical, mechanical, thermal)
- Biological hazards (biocompatibility, infection)
- Chemical hazards (toxicity, flammability)
- Operational hazards (use errors, failures)
- Information hazards (labeling, instructions)

**Initial Risk Estimation**
For each hazard, estimate:
- Probability of harm occurrence
- Severity of potential harm
- Create initial risk matrix

### Design Development Phase

**Design Inputs**
Risk analysis informs design requirements:
- Safety requirements from hazard analysis
- Performance requirements with safety margins
- Usability requirements to prevent use errors
- Testing requirements for risk verification

**Design Reviews**
Risk review at each design milestone:
- Verify hazards addressed by design
- Evaluate new hazards introduced
- Assess effectiveness of risk controls
- Update risk management file

**Design Verification and Validation**
- Test risk controls for effectiveness
- Validate intended use scenarios
- Conduct usability testing
- Verify software risk controls

### Risk Control Implementation

**Control Option Hierarchy**
1. Inherent safety by design
2. Protective measures in device or manufacturing
3. Information for safety (labeling, instructions)

**Risk-Benefit Analysis**
For each residual risk:
- Document rationale for acceptability
- Compare against state of the art
- Consider patient population characteristics
- Evaluate alternative designs

## Risk Management in Manufacturing

### Process Risk Assessment

**Manufacturing Hazards**
Identify risks introduced by manufacturing:
- Process variability impacts
- Contamination sources
- Human error opportunities
- Equipment failure modes

**Process FMEA**
Systematic analysis of manufacturing processes:
- Identify potential failure modes
- Estimate severity, occurrence, detection
- Calculate risk priority numbers
- Implement controls for high-priority risks

### Production Controls

**Process Validation**
- Validate processes affecting risk controls
- Establish process parameters maintaining safety
- Define monitoring requirements
- Document validation evidence

**Inspection and Testing**
Risk-based inspection planning:
- Critical-to-safety characteristics
- Appropriate sampling levels
- Acceptance criteria based on risk
- Traceability requirements

### Change Management

**Risk Impact Assessment**
Evaluate changes for risk impact:
- Design changes
- Process changes
- Supplier changes
- Material changes

**Re-validation Requirements**
Determine validation needs based on:
- Risk impact of change
- Affected risk controls
- New hazards introduced

## Post-Market Risk Management

### Information Collection

**Data Sources**
- Customer complaints
- Field service reports
- Vigilance/MDR data
- Literature monitoring
- Post-market clinical follow-up

**Trend Analysis**
- Track complaint rates over time
- Identify emerging hazards
- Compare against expectations
- Statistical significance assessment

### Risk Re-evaluation

**Triggers for Review**
- New hazard information
- Increased frequency of events
- Severity different than estimated
- New use scenarios identified
- Regulatory or standards changes

**Risk File Updates**
- Revise risk estimation as needed
- Evaluate need for additional controls
- Update benefit-risk analysis
- Document rationale for conclusions

### Post-Market Actions

**Field Actions**
When risks exceed acceptable levels:
- Field safety corrective actions
- Recalls when necessary
- Customer notifications
- Regulatory reporting

**Product Improvements**
Risk-based prioritization of improvements:
- Design updates
- Labeling enhancements
- Training modifications
- Process improvements

## Risk Management File

### Required Contents
- Risk management plan
- Hazard identification and analysis
- Risk evaluation records
- Risk control measures
- Residual risk evaluation
- Risk management report
- Post-production information

### Maintenance
- Keep file current throughout lifecycle
- Document rationale for decisions
- Include traceability to design outputs
- Make accessible for inspections

## Integration with Quality System

### Design Controls
- Risk management integral to design process
- Design reviews include risk review
- Design outputs address risk controls
- DHF includes risk management file

### CAPA
- Risk used to prioritize CAPAs
- Risk assessment for CAPA actions
- Risk file updated based on findings

### Management Review
- Risk trends reviewed regularly
- Resource allocation based on risk
- Strategic decisions consider risk

## Common Challenges

### Challenge 1: Maintaining Currency
**Issue**: Risk file becomes outdated
**Solution**: Scheduled reviews, triggers for update, ownership assignment

### Challenge 2: Subjectivity
**Issue**: Inconsistent risk estimation
**Solution**: Training, calibration exercises, team-based estimation

### Challenge 3: Completeness
**Issue**: Missing hazards or scenarios
**Solution**: Systematic methods, cross-functional teams, external review

### Challenge 4: Documentation Burden
**Issue**: Excessive documentation requirements
**Solution**: Scalable approaches, templates, electronic tools

## Conclusion

Effective risk management throughout the medical device lifecycle is essential for patient safety and regulatory compliance. Success requires systematic processes, cross-functional involvement, and continuous attention from design through post-market. When implemented well, risk management becomes a valuable tool for decision-making rather than a documentation burden.`,
      featuredImage: "https://images.unsplash.com/photo-1551288049-bebda4e38f71?w=1200",
      status: PostStatus.PUBLISHED,
      publishedAt: new Date("2025-11-05"),
      metaTitle: "Medical Device Risk Management Throughout Lifecycle | SIDEC Consult",
      metaDescription: "Comprehensive guide to implementing ISO 14971 risk management across design, manufacturing, and post-market phases for medical devices.",
      readingTime: 12,
      categorySlug: "quality-systems-compliance",
    },

    // =========================================================================
    // PROCESS DEVELOPMENT (4 posts)
    // =========================================================================
    {
      title: "Scientific Molding: A Data-Driven Approach to Injection Molding",
      slug: "scientific-molding-data-driven-approach-injection-molding",
      excerpt: "Master the principles of scientific molding to achieve consistent, validated injection molding processes for medical device components.",
      content: `## Introduction

Scientific molding represents a fundamental shift from traditional trial-and-error injection molding to a systematic, data-driven approach. For medical device manufacturers, this methodology is essential for developing robust, validated processes that consistently produce high-quality parts.

## What is Scientific Molding?

Scientific molding is an approach that uses polymer science, thermodynamics, and systematic experimentation to develop and optimize injection molding processes. Rather than adjusting machine settings arbitrarily, scientific molding uses data to understand and control the process.

### Core Principles
1. **Plastic-centric thinking**: Focus on what the plastic experiences, not just machine settings
2. **Decoupled molding**: Separate fill, pack, and hold phases
3. **Data-driven decisions**: Use measurements, not opinions
4. **Process documentation**: Record the science, not just settings

## The Scientific Molding Methodology

### Phase 1: Rheology Study (Viscosity Curve)

**Purpose**: Understand how the material flows at different speeds

**Procedure**:
1. Set pack/hold to zero (fill only)
2. Establish consistent shot size
3. Run parts at varying injection speeds
4. Record fill time, peak pressure, part weight

**Analysis**:
- Plot relative viscosity vs. injection speed
- Identify optimal velocity range (flat portion of curve)
- Determine velocity for process development

**Key Insight**: Viscosity changes with shear rate. Finding the region where viscosity is relatively stable helps create a robust process.

### Phase 2: Cavity Balance Study

**Purpose**: Verify uniform filling across all cavities

**Procedure**:
1. Use optimal velocity from Phase 1
2. Short-shot to 95-98% fill
3. Weigh parts from each cavity
4. Calculate variation percentage

**Acceptance Criteria**:
- Typically <5% variation between cavities
- Higher variation indicates mold or runner issues

**Corrective Actions**:
- Runner size adjustments
- Gate modifications
- Temperature corrections

### Phase 3: Pressure Drop Study

**Purpose**: Understand pressure requirements through the system

**Procedure**:
1. Measure pressure at different points:
   - Nozzle to runner
   - Runner to gate
   - Gate to end of fill
2. Calculate percentage of available pressure used

**Analysis**:
- Identify pressure constraints
- Determine if adequate pressure available for pack
- Identify areas for improvement

### Phase 4: Gate Seal Study

**Purpose**: Determine minimum hold time for gate freeze

**Procedure**:
1. Set appropriate pack pressure
2. Start with short hold time
3. Progressively increase hold time
4. Weigh parts at each hold time
5. Plot weight vs. hold time

**Analysis**:
- Identify where weight stabilizes
- Gate seal occurs at weight plateau
- Add safety margin for process

**Result**: Minimum hold time that ensures part quality without wasted cycle time

### Phase 5: Cooling Study

**Purpose**: Determine optimal cooling time

**Procedure**:
1. Start with estimated cooling time
2. Progressively reduce cooling
3. Monitor for:
   - Ejection issues
   - Part distortion
   - Dimensional changes

**Analysis**:
- Find minimum cooling time meeting quality requirements
- Balance cycle time vs. part quality
- Consider downstream operations

### Phase 6: Process Window Development

**Purpose**: Establish operating ranges for critical parameters

**Procedure**:
1. Vary each critical parameter systematically
2. Test at high and low settings
3. Evaluate part quality at each condition
4. Document acceptable ranges

**Parameters to Study**:
- Melt temperature
- Mold temperature
- Injection velocity
- Pack pressure
- Hold time
- Cooling time

**Documentation**:
- Upper and lower limits for each parameter
- Effect of parameter on quality attributes
- Interaction effects between parameters

## Process Validation Connection

### IQ/OQ/PQ Framework

**Installation Qualification (IQ)**:
- Equipment installed correctly
- Utilities meet specifications
- Calibration current
- Documentation complete

**Operational Qualification (OQ)**:
- Process operates within specified ranges
- Challenge process at limits
- All critical parameters tested
- Results meet acceptance criteria

**Performance Qualification (PQ)**:
- Demonstrate consistent production
- Extended run at normal conditions
- Statistical process capability
- Documentation of production capability

### Using Scientific Molding Data

Scientific molding studies provide:
- Justification for parameter ranges
- Understanding of process sensitivities
- Data for risk assessment
- Foundation for control strategy

## Process Monitoring and Control

### Critical Process Parameters
Based on scientific molding studies, identify:
- Parameters with significant impact
- Appropriate control limits
- Monitoring frequency
- Action levels

### In-Process Monitoring
- Cavity pressure monitoring
- Injection pressure profiling
- Temperature trending
- Cycle time tracking

### Statistical Process Control
- Control charts for key parameters
- Capability studies (Cpk)
- Trend analysis
- Out-of-control response

## Troubleshooting with Scientific Molding

### Systematic Approach
1. Define the problem precisely
2. Review baseline process data
3. Identify potential causes based on polymer science
4. Test hypotheses systematically
5. Implement and verify solutions

### Common Issues and Scientific Solutions

**Short Shots**:
- Check viscosity curve position
- Evaluate pressure availability
- Review gate seal study

**Flash**:
- Evaluate clamp force adequacy
- Check cavity pressure profile
- Review mold condition

**Warpage**:
- Evaluate cooling uniformity
- Check gate seal timing
- Review pack pressure profile

**Sink Marks**:
- Review pack pressure adequacy
- Check gate seal completion
- Evaluate cooling effectiveness

## Conclusion

Scientific molding transforms injection molding from an art to a science. For medical device manufacturers, this systematic approach is essential for developing validated processes that consistently produce high-quality components. Investment in scientific molding methodology pays dividends in reduced scrap, faster development, and more robust production.`,
      featuredImage: "https://images.unsplash.com/photo-1581091226825-a6a2a5aee158?w=1200",
      status: PostStatus.PUBLISHED,
      publishedAt: new Date("2025-10-30"),
      metaTitle: "Scientific Molding for Medical Device Manufacturing | SIDEC Consult",
      metaDescription: "Master data-driven injection molding with scientific molding methodology for validated medical device component production.",
      readingTime: 11,
      categorySlug: "process-development",
    },
    {
      title: "Process Validation for Injection Molding: IQ, OQ, PQ Best Practices",
      slug: "process-validation-injection-molding-iq-oq-pq",
      excerpt: "A practical guide to executing Installation, Operational, and Performance Qualification for injection molding processes in medical device manufacturing.",
      content: `## Introduction

Process validation is a regulatory requirement for medical device manufacturing, ensuring that processes consistently produce products meeting predetermined specifications. For injection molding, this means systematically demonstrating that your equipment, process, and controls reliably produce conforming parts.

## Regulatory Foundation

### FDA Requirements
21 CFR 820.75 requires that processes whose results cannot be fully verified by subsequent inspection and test be validated. For injection molding:
- Many critical dimensions may require destructive testing
- Internal stresses and molecular orientation affect performance
- Material properties can be affected by processing

### ISO 13485 Requirements
Section 7.5.6 requires validation of production processes where resulting output cannot be verified by subsequent monitoring or measurement.

## The Three Phases of Process Validation

### Installation Qualification (IQ)

**Purpose**: Verify equipment is installed correctly per manufacturer specifications.

**Key Elements**:

**Equipment Documentation**
- Equipment manual and specifications
- Preventive maintenance requirements
- Calibration requirements
- Safety documentation

**Installation Verification**
- Equipment matches purchase specifications
- Utilities meet requirements (electrical, water, air)
- Environment meets specifications
- Safety interlocks function correctly

**Typical IQ Activities**:
1. Verify equipment model and serial numbers
2. Confirm utility connections meet specifications
3. Verify calibration of instruments
4. Document software version (if applicable)
5. Verify safety systems functional
6. Confirm PM schedule established

**Documentation**:
- IQ protocol with acceptance criteria
- Completed verification checklists
- Calibration certificates
- Deviation reports (if any)
- IQ summary report

### Operational Qualification (OQ)

**Purpose**: Demonstrate process operates correctly throughout specified operating ranges.

**Pre-OQ Requirements**:
- IQ completed and approved
- Operators trained
- Procedures finalized
- Test methods validated

**Process Parameter Challenges**:

Test at upper and lower limits of:
- Melt temperature
- Mold temperature
- Injection speed/pressure
- Pack/hold parameters
- Cooling time
- Cycle time

**Typical OQ Structure**:

**Phase 1: Nominal Conditions**
- Establish baseline at nominal settings
- Verify process stability
- Confirm part quality meets specifications

**Phase 2: Parameter Challenge**
- Test each parameter at limits
- Evaluate impact on critical quality attributes
- Identify any failing conditions

**Phase 3: Worst Case Combinations**
- Combine parameters likely to cause issues
- Document acceptable operating space

**Acceptance Criteria**:
- Parts meet all specifications at all tested conditions
- Process remains stable (no trending)
- No safety issues observed

### Performance Qualification (PQ)

**Purpose**: Demonstrate process consistently produces conforming product under actual production conditions.

**Pre-PQ Requirements**:
- OQ completed and approved
- Production personnel trained
- All procedures finalized
- Raw materials qualified

**PQ Study Design**:

**Duration**: Typically 3 consecutive production lots or runs

**Sample Size**: Based on:
- Production volume
- Risk level of device
- Historical process capability
- Statistical requirements

**Testing**: All critical quality attributes per device specifications

**Production Conditions**:
- Normal production personnel
- Normal production schedule
- Normal environmental conditions
- Multiple material lots (when practical)

**Statistical Requirements**:
- Demonstrate process capability (typically Cpk ≥ 1.33)
- Sample size adequate for statistical confidence
- Document any out-of-specification results

## Protocol Development

### Protocol Content

**Scope and Objectives**
- Clear statement of what's being validated
- Specific objectives for each phase

**Responsibilities**
- Protocol preparation and approval
- Execution responsibilities
- Data review and approval

**Equipment and Materials**
- Equipment identification
- Material specifications and lot numbers
- Tooling identification

**Procedures**
- Step-by-step execution instructions
- Sampling plans
- Test methods referenced

**Acceptance Criteria**
- Specific, measurable criteria for each test
- Pass/fail determination rules

**Documentation Requirements**
- Data collection forms
- Deviation handling procedures
- Report requirements

### Common Challenges

**Challenge 1: Parameter Selection**
- Use scientific molding studies to justify ranges
- Consider process capability data
- Reference equipment specifications

**Challenge 2: Sample Size**
- Balance statistical requirements with cost
- Consider risk level of device
- Document rationale for chosen sample size

**Challenge 3: Acceptance Criteria**
- Derive from device specifications
- Consider measurement uncertainty
- Be specific and measurable

## Maintaining Validation

### Revalidation Triggers

Changes requiring evaluation:
- Equipment modifications
- Process parameter changes outside validated ranges
- Material changes
- Tooling modifications
- Software updates

### Periodic Review
- Annual process review recommended
- Evaluate process data trends
- Review nonconformance history
- Assess any changes made

### Change Control Integration
- All changes evaluated for validation impact
- Revalidation scope determined by risk assessment
- Documentation maintained in validation file

## Documentation Best Practices

### Validation Master Plan
- Overall validation strategy
- Validation schedule
- Resource allocation
- Documentation requirements

### Protocol Structure
- Clear, step-by-step instructions
- Unambiguous acceptance criteria
- Traceability to requirements

### Data Integrity
- Real-time data recording
- No blank spaces or overwrites
- Clear corrections with rationale

### Reports
- Summary of objectives and results
- Deviations and resolutions
- Conclusion statements
- Approval signatures

## Conclusion

Injection molding process validation requires systematic planning and execution. By following IQ/OQ/PQ methodology with appropriate protocols and documentation, manufacturers can demonstrate regulatory compliance while building confidence in their processes. The key is treating validation as a comprehensive demonstration of process understanding, not just a documentation exercise.`,
      featuredImage: "https://images.unsplash.com/photo-1581092162384-8987c1d64926?w=1200",
      status: PostStatus.PUBLISHED,
      publishedAt: new Date("2025-10-25"),
      metaTitle: "Process Validation IQ OQ PQ for Injection Molding | SIDEC Consult",
      metaDescription: "Practical guide to IQ, OQ, PQ process validation for injection molding in medical device manufacturing with best practices and templates.",
      readingTime: 10,
      categorySlug: "process-development",
    },
  ];

  // Create blog posts
  let postsCreated = 0;
  for (const post of blogPosts) {
    const categoryId = categoryMap[post.categorySlug];
    
    await prisma.blogPost.upsert({
      where: { slug: post.slug },
      update: {
        title: post.title,
        excerpt: post.excerpt,
        content: post.content,
        featuredImage: post.featuredImage,
        status: post.status,
        publishedAt: post.publishedAt,
        metaTitle: post.metaTitle,
        metaDescription: post.metaDescription,
        readingTime: post.readingTime,
        categoryId: categoryId,
        authorId: adminUser.id,
      },
      create: {
        title: post.title,
        slug: post.slug,
        excerpt: post.excerpt,
        content: post.content,
        featuredImage: post.featuredImage,
        status: post.status,
        publishedAt: post.publishedAt,
        metaTitle: post.metaTitle,
        metaDescription: post.metaDescription,
        readingTime: post.readingTime,
        categoryId: categoryId,
        authorId: adminUser.id,
      },
    });
    postsCreated++;
  }

  console.log(`✅ Created ${postsCreated} blog posts`);

  // =============================================================================
  // SEED SERVICES
  // =============================================================================
  console.log("🛠️  Creating services...");

  const services = [
    // Manufacturing & Operations Category
    {
      categoryName: "Manufacturing & Operations",
      categorySlug: "manufacturing-operations",
      categoryIcon: "Factory",
      categoryColor: "from-blue-500/20 to-blue-600/10",
      categoryBorder: "border-blue-500/30",
      serviceId: "manufacturing-engineering",
      icon: "Settings",
      title: "Manufacturing Engineering & Operations",
      tagline: "Build World-Class Manufacturing Capabilities",
      description: "We help medical device companies build and optimize their manufacturing engineering organizations. From talent development to process optimization, we deliver sustainable improvements that drive quality and efficiency.",
      keyOfferings: [
        "Manufacturing engineering team development and organizational design",
        "Process optimization and continuous improvement programs",
        "Lean manufacturing and Six Sigma implementation",
        "Equipment selection, qualification, and optimization",
        "Manufacturing cost reduction strategies",
        "Production capacity planning and scaling",
      ],
      outcomes: [
        "Reduced manufacturing costs by 15-30%",
        "Improved first-pass yield rates",
        "Faster time-to-market for new products",
        "Sustainable internal capabilities",
      ],
      sortOrder: 1,
    },
    {
      categoryName: "Manufacturing & Operations",
      categorySlug: "manufacturing-operations",
      categoryIcon: "Factory",
      categoryColor: "from-blue-500/20 to-blue-600/10",
      categoryBorder: "border-blue-500/30",
      serviceId: "equipment-maintenance",
      icon: "Wrench",
      title: "Equipment & Mold Maintenance",
      tagline: "Maximize Equipment Uptime and Performance",
      description: "Effective maintenance programs are critical to manufacturing success. We help companies implement preventive and predictive maintenance strategies that maximize equipment availability and extend asset life.",
      keyOfferings: [
        "Preventive maintenance program development",
        "Mold maintenance standards and procedures",
        "CMMS (Computerized Maintenance Management System) selection and implementation",
        "Spare parts inventory optimization",
        "Equipment lifecycle management",
        "Maintenance team training and development",
        "TPM (Total Productive Maintenance) implementation",
        "Equipment reliability analysis",
      ],
      outcomes: [
        "Increased equipment uptime (OEE)",
        "Extended mold and equipment life",
        "Reduced unplanned downtime",
        "Optimized maintenance costs",
      ],
      sortOrder: 2,
    },
    // Quality & Compliance Category
    {
      categoryName: "Quality & Compliance",
      categorySlug: "quality-compliance",
      categoryIcon: "Scale",
      categoryColor: "from-emerald-500/20 to-emerald-600/10",
      categoryBorder: "border-emerald-500/30",
      serviceId: "quality-regulatory",
      icon: "ShieldCheck",
      title: "Quality & Regulatory Compliance",
      tagline: "Navigate Regulatory Requirements with Confidence",
      description: "With director-level quality management experience, we help companies build robust quality systems that satisfy FDA, ISO, and global regulatory requirements while remaining practical and efficient to operate.",
      keyOfferings: [
        "ISO 13485 Quality Management System implementation",
        "FDA 21 CFR Part 820 compliance programs",
        "EU MDR (2017/745) transition and compliance",
        "MDSAP certification preparation",
        "510(k) submission support and strategy",
        "Design controls and risk management (ISO 14971)",
        "CAPA system optimization",
        "Audit preparation (FDA, Notified Bodies, customers)",
      ],
      outcomes: [
        "Successful regulatory submissions",
        "Clean audit results",
        "Efficient quality systems",
        "Reduced compliance burden",
      ],
      sortOrder: 3,
    },
    // Process & Technical Excellence Category
    {
      categoryName: "Process & Technical Excellence",
      categorySlug: "process-technical",
      categoryIcon: "Layers",
      categoryColor: "from-violet-500/20 to-violet-600/10",
      categoryBorder: "border-violet-500/30",
      serviceId: "injection-molding",
      icon: "Cog",
      title: "Injection Molding Process Excellence",
      tagline: "Master the Science of Injection Molding",
      description: "As recognized internal molding subject matter experts, we bring deep technical expertise in scientific molding methodology, process development, and troubleshooting. We help companies achieve consistent, validated processes that deliver quality parts.",
      keyOfferings: [
        "Scientific molding methodology implementation",
        "Process development and optimization",
        "Design of Experiments (DOE) studies",
        "Process validation (IQ/OQ/PQ)",
        "Mold qualification and capability studies",
        "Process troubleshooting and root cause analysis",
        "Automation and robotics integration",
        "Material selection and qualification",
      ],
      outcomes: [
        "Robust, validated processes",
        "Reduced scrap and rework",
        "Improved cycle times",
        "Consistent part quality",
      ],
      sortOrder: 4,
    },
    {
      categoryName: "Process & Technical Excellence",
      categorySlug: "process-technical",
      categoryIcon: "Layers",
      categoryColor: "from-violet-500/20 to-violet-600/10",
      categoryBorder: "border-violet-500/30",
      serviceId: "facility-design",
      icon: "Building",
      title: "Facility Design & Infrastructure",
      tagline: "Design Facilities Built for Manufacturing Excellence",
      description: "We've built facilities from the ground up. From greenfield site selection to cleanroom design, we help companies create manufacturing environments that support quality, efficiency, and regulatory compliance.",
      keyOfferings: [
        "Greenfield and brownfield facility planning",
        "Cleanroom design and classification (ISO 7/8)",
        "Production floor layout optimization",
        "Utility systems design (compressed air, cooling, electrical)",
        "Material flow and logistics optimization",
        "Environmental monitoring systems",
        "EHS (Environmental Health & Safety) compliance",
        "Facility expansion and renovation planning",
      ],
      outcomes: [
        "Optimized production flow",
        "Regulatory-compliant facilities",
        "Efficient space utilization",
        "Scalable infrastructure",
      ],
      sortOrder: 5,
    },
    // Strategy & Supply Chain Category
    {
      categoryName: "Strategy & Supply Chain",
      categorySlug: "strategy-supply-chain",
      categoryIcon: "Rocket",
      categoryColor: "from-amber-500/20 to-amber-600/10",
      categoryBorder: "border-amber-500/30",
      serviceId: "supplier-development",
      icon: "Globe",
      title: "Supplier Development & Global Supply Chain",
      tagline: "Build a Resilient Global Supply Network",
      description: "With experience developing suppliers across six continents, we help companies build robust supply chains. From supplier qualification to ongoing development, we ensure your supply base meets quality and delivery requirements.",
      keyOfferings: [
        "Global supplier strategy development",
        "Supplier qualification and approval programs",
        "Supplier quality management systems",
        "Supplier audits and assessments",
        "Supply chain risk management",
        "Dual-sourcing and localization strategies",
        "Supplier performance management (scorecards, reviews)",
        "Contract manufacturing management",
      ],
      outcomes: [
        "Qualified, reliable supplier base",
        "Reduced supply chain risk",
        "Improved supplier quality",
        "Optimized total cost of ownership",
      ],
      sortOrder: 6,
    },
    {
      categoryName: "Strategy & Supply Chain",
      categorySlug: "strategy-supply-chain",
      categoryIcon: "Rocket",
      categoryColor: "from-amber-500/20 to-amber-600/10",
      categoryBorder: "border-amber-500/30",
      serviceId: "strategic-advisory",
      icon: "Lightbulb",
      title: "Strategic Advisory & Expert Services",
      tagline: "Expert Guidance for Critical Decisions",
      description: "We provide strategic advisory services for complex situations requiring deep expertise. From technology transfer to M&A due diligence, we help companies navigate critical decisions with confidence.",
      keyOfferings: [
        "Technology transfer planning and execution",
        "Due diligence for mergers and acquisitions",
        "Expert witness services for litigation",
        "Custom training program development",
        "Manufacturing strategy consulting",
        "Make vs. buy analysis",
        "Competitive benchmarking",
        "Organizational capability assessments",
      ],
      outcomes: [
        "Informed strategic decisions",
        "Successful technology transfers",
        "Risk mitigation",
        "Knowledge transfer to your team",
      ],
      sortOrder: 7,
    },
  ];

  let servicesCreated = 0;
  for (const service of services) {
    await prisma.service.upsert({
      where: { serviceId: service.serviceId },
      update: service,
      create: service,
    });
    servicesCreated++;
  }

  console.log(`✅ Created ${servicesCreated} services`);

  // =============================================================================
  // SUMMARY
  // =============================================================================
  console.log("\n🎉 Database seed completed successfully!");
  console.log("━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━");
  console.log(`📁 Categories: ${categories.length}`);
  console.log(`👤 Admin user: ${adminUser.email}`);
  console.log(`📝 Blog posts: ${postsCreated}`);
  console.log(`🛠️  Services: ${servicesCreated}`);
  console.log("━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━");
  console.log("\n⚠️  IMPORTANT: Change the admin password after first login!");
}

main()
  .catch((e) => {
    console.error("❌ Error seeding database:", e);
    process.exit(1);
  })
  .finally(async () => {
    await prisma.$disconnect();
  });
